CD200 and neuroblastoma: In this context, lack of immunotherapeutic targets, like programmed cell death ligand-1 (PD-L1), in CD24 overexpressing NB, as well as amplification of multidrug resistance-associated genes and overexpression of immune checkpoint molecule CD200 in NB is of particular interest (35–38).